Saturday, May 31, 2025

Latest

Medipharm Labs Announces White Label Agreement, Provides No Details

Medipharm Labs (TSX: LABS) has entered into its second white label supply agreement with its Australian counterpart for the New Zealand market. The white label agreement will see the firms Australian division supply Cannasouth Plant Research New Zealand Limited with cannabis oil products.

While Medipharm Labs determined that the contract was material enough to make a news release in relation to it, evidently the specific details of the contract were not. The company identified that the supply agreement will be for a period of two years, with Medipharm supplying GMP certified cannabis oil to Cannasouth. Additionally, Cannasouth will be the exclusive purchaser of “certain formulations and dosage forms.”

And that’s where the details end of the supposedly material contract. It’s unclear what the value of the agreement amounts to, associated quantities agreed to under the agreement, or just what part exactly makes the news overly material for a firm that generated $129.2 million in revenues for 2019.

The supply arrangement itself is contingent on confirmation that products meet quality standards outlined by New Zealand Medicines and Medical Devices Safety Authority, and Cannasouth confirming certain insurance requirements.

Medipharm Labs last traded at $1.82 on the TSX.


Information for this briefing was found via Sedar and MediPharm Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Alamos Gold Q1 Earnings: The Inside Scoop

Cerrado Gold Q4 Earnings: The Turnaround is Working

B2GOLD Q1 Earnings: Revenue Up, Production & Cash Flow Decline

Recommended

Canadian Copper: The $172M Combined Strategy PEA

ESGold Begins Concentration Tests Ahead Of First Production

Related News

MediPharm Labs Posts Revenues Of $5.5 Million, Net Loss Of $13.9 Million

MediPharm Labs (TSX: LABS) this morning continued its recent trend of dismal financing results, posting...

Monday, May 17, 2021, 07:54:52 AM

Medipharm Labs Closes $33.4 Million Bought Deal Financing

Medipharm Labs (TSX: LABS) has closed the bought deal financing that it announced and then...

Friday, March 5, 2021, 09:12:09 AM

Medipharm Labs Launches Self-Branded Line Of Products

Medipharm Labs (TSX: LABS) is launching its first branded products to the Canadian marketplace. This...

Thursday, March 26, 2020, 08:33:37 AM

Medipharm Labs Revenues Crater 64.5% Quarter Over Quarter To $4.9 Million

It appears that not all operators are able to successfully perform under the changing market...

Monday, November 16, 2020, 08:01:12 AM

Medipharm Labs Posts Revenues of $13.9 Million, Net Loss of $3.5 Million For Q2 2020

Medipharm Labs (TSX: LABS) reported further disappointing quarterly results this morning, with revenues of $13.9...

Thursday, August 13, 2020, 09:25:18 AM